In case you missed it: April 25 to April 29
A look back at the week's news.
This week's top headlines:
FDA warn public of risks, false results with noninvasive prenatal screening tests
The FDA recently issued a statement warning the public of the risks and potential false results obtained with noninvasive prenatal screening tests, noting that inappropriate usage and interpretation has resulted in improper medical decisions.
Coronavirus Omicron variant, vaccine, and case numbers in the United States: April 28, 2022
Omicron by the numbers.
Women’s health in review: April 2022
A look back at this month’s most popular stories, according to you.
Rotating shift work and onset of menopause
A Canadian study in Menopause suggests shift work may increase women's likelihood to experience delayed onset of menopause.
Prescription spending rose 12% in 2021
A report that tracks the use of medicines in the United States shows that spending on prescriptions rose 12% in 2021 primarily due to COVID-19 vaccines and therapies.
Rising endometriosis rates linked to increased pregnancy complications
May 19th 2024A new study presented at the 2024 ACOG meeting reveals a significant rise in endometriosis among pregnant women over the past 20 years, linking the condition to increased obstetric and neonatal complications.
Read More
Laparoscopic RFA linked to enhanced pregnancy outcomes in uterine fibroid patients
May 18th 2024A recent study presented at the 2024 ACOG Clinical and Scientific Meeting reveals that laparoscopic radiofrequency ablation significantly improves pregnancy outcomes for women with uterine leiomyomas.
Read More
